跳至主要内容
临床试验/ISRCTN82045842
ISRCTN82045842进行中(未招募)未知

Prospective randomised controlled study: Adept and Conserve Plus Hip Resurfacing Devices

MatOrtho Limited0 个研究点目标入组 46 人开始时间: 2017年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Requires primary hip arthroplasties
  • 2. Between the age of 18 and 60 years at time of surgery
  • 3. Good femoral bone stock as determined by the surgeon
  • 4. Understand the conditions of the study and are willing to participate for the length of the prescribed term of follow-up
  • 5. Capable of, and have given, informed consent to their participation in the study

排除标准

  • 1. Previous metal work in situ
  • 2. Previous femoral or pelvic osteotomy
  • 3. Dysplasia of the hip requiring structural graft
  • 4. Osteopenia or osteoporosis
  • 5. Hepatic or renal insufficiency
  • 6. Contralateral total or resurfacing hip prosthesis, or patients requiring bilateral hip replacement
  • 7. Planning to become, or who are, pregnant

研究者

相似试验